SCHEMBL6077445

SCHEMBL6077445

CCCCc1cc(Br)c2nc(C)c(C)c(OCc3ccccc3)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 6/20 0.42
THRB P10828 6/20 0.42
TSHR P16473 1/20 0.37
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
PDE3B Q13370 1/20 0.36
PDE3A Q14432 1/20 0.36
PTGER1 P34995 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
STAT3 P40763 1/20 0.36
HTT P42858 1/20 0.36
PTGES O14684 1/20 0.35
ALOX5 P09917 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PSMB5 P28074 1/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6078590 0.84 L3MBTL1 (0.38) TSHRPDE4APDE4BPDE4CPDE4D
SCHEMBL6077441 0.79 TDP1 (0.36) THRATHRBTSHRSMN1; SMN2STAT3
SCHEMBL6076329 0.76 SMN1; SMN2 (0.40) THRATHRBTSHRSMN1; SMN2STAT3
SCHEMBL6076162 0.74 NPC1 (0.41) THRATHRBSMN1; SMN2HTTTP53
SCHEMBL6077263 0.70 TSHR (0.36) TSHRSMN1; SMN2STAT3HTTL3MBTL1
SCHEMBL26608216 0.70 L3MBTL1 (0.47) THRATHRBTSHRSMN1; SMN2STAT3
SCHEMBL9007521 0.68 PARP1 (0.41) TSHRPDE4APDE4BPDE4CPDE4D
SCHEMBL3103639 0.68 L3MBTL1 (0.50) TSHRSMN1; SMN2STAT3HTTL3MBTL1
SCHEMBL6078583 0.66 SMN1; SMN2 (0.35) TSHRSMN1; SMN2STAT3HTTL3MBTL1
SCHEMBL15326688 0.66 THRA (0.49) THRATHRBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067668-B2 4-quinolinol derivatives and fungicides containing the same as an active ingredient used for agriculture and horticulture MEIJI SEIKA KAISHA, LTD. (JP) 2006-06-27 US disclosed
EP-0990648-B1 4-QUINOLINOL DERIVATIVES AND AGROHORTICULTURAL BACTERICIDES CONTAINING THE SAME AS ACTIVE INGREDIENT MEIJI SEIKA KAISHA (JP) 2005-11-02 EP disclosed
US-20040152728-A1 4-Quinolinol derivatives and fungicides containing the same as an active ingredient used for agriculture and horticulture MEIJI SEIKA KAISHA, LTD. (JP) 2004-08-05 US disclosed
US-6680282-B2 FUNGICIDE HAVING AN EXCELLENT CONTROL EFFECT; 4-QUINOLINOL DERIVATIVES HAVING SPECIFIC SUBSTITUENT AT 1,2 AND ATLEAST ONE SUBSTITUENT AT 5,6,7,8 POSITION MEIJI SEIKA KAISHA, LTD. (JP) 2004-01-20 US disclosed
US-20030119863-A1 4-Quinolinol derivatives and agrohorticultural bactericides containing the same as active ingredient MEIJI SEIKA PHARMA CO., LTD. (JP) 2003-06-26 US disclosed
EP-0990648-A1 4-QUINOLINOL DERIVATIVES AND AGROHORTICULTURAL BACTERICIDES CONTAINING THE SAME AS ACTIVE INGREDIENT Meiji Seika Kaisha, Ltd. (JP) 2000-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152728-A1 4-Quinolinol derivatives and fungicides containing the same as an active ingredient used for agriculture and horticulture CYP51A1, CYP4X1, CYP4Z1 THRA 3358/4885THRB 4192/4885TSHR 4067/4885
US-20030119863-A1 4-Quinolinol derivatives and agrohorticultural bactericides containing the same as active ingredient CYP51A1, DDT, PGLS THRA 4489/4885THRB 4585/4885TSHR 4551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.